BRPI0408205A - substituted aniline derivative, pharmaceutical composition, and, use of a pharmaceutical composition - Google Patents
substituted aniline derivative, pharmaceutical composition, and, use of a pharmaceutical compositionInfo
- Publication number
- BRPI0408205A BRPI0408205A BRPI0408205-2A BRPI0408205A BRPI0408205A BR PI0408205 A BRPI0408205 A BR PI0408205A BR PI0408205 A BRPI0408205 A BR PI0408205A BR PI0408205 A BRPI0408205 A BR PI0408205A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- aniline derivative
- substituted aniline
- aniline
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- AIDS & HIV (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"DERIVADO DE ANILINA SUBSTITUìDO COMPOSIçãO FARMACêUTICA, E, USO DE UMA COMPOSIçãO FARMACêUTICA". A presente invenção diz respeito aos derivados de anilina da fórmula geral I ou sais farmaceuticamente aceitáveis destes e seu uso."ANILINE DERIVATIVE REPLACING PHARMACEUTICAL COMPOSITION, AND USE OF A PHARMACEUTICAL COMPOSITION". The present invention relates to aniline derivatives of general formula I or pharmaceutically acceptable salts thereof and their use.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45458003P | 2003-03-14 | 2003-03-14 | |
DKPA200300392 | 2003-03-14 | ||
PCT/DK2004/000162 WO2004080950A1 (en) | 2003-03-14 | 2004-03-12 | Substituted aniline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0408205A true BRPI0408205A (en) | 2006-02-14 |
Family
ID=32992158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0408205-2A BRPI0408205A (en) | 2003-03-14 | 2004-03-12 | substituted aniline derivative, pharmaceutical composition, and, use of a pharmaceutical composition |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1606247A1 (en) |
JP (1) | JP2006520333A (en) |
AU (1) | AU2004220424B2 (en) |
BR (1) | BRPI0408205A (en) |
CA (1) | CA2519061A1 (en) |
MX (1) | MXPA05009282A (en) |
WO (1) | WO2004080950A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050089559A1 (en) | 2003-10-23 | 2005-04-28 | Istvan Szelenyi | Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
UA89503C2 (en) | 2004-09-13 | 2010-02-10 | Х. Луннбек А/С | Substituted aniline derivatives |
EP1983974A1 (en) * | 2006-02-07 | 2008-10-29 | H. Lundbeck A/S | Use of kcnq-openers for treating or reducing the symptoms of schizophrenia |
US7960436B2 (en) | 2006-06-05 | 2011-06-14 | Valeant Pharmaceuticals International | Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators |
US8993593B2 (en) | 2006-08-23 | 2015-03-31 | Valeant Pharmaceuticals International | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators |
WO2008024398A2 (en) | 2006-08-23 | 2008-02-28 | Valeant Pharmaceuticals International | Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
US8722929B2 (en) | 2006-10-10 | 2014-05-13 | Valeant Pharmaceuticals International | N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators |
MX2009005652A (en) | 2006-11-28 | 2009-08-07 | Valeant Pharmaceuticals Int | 1,4 diamino bicyclic retigabine analogues as potassium channel modulators. |
US8367684B2 (en) | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
WO2009015667A1 (en) * | 2007-08-01 | 2009-02-05 | H. Lundbeck A/S | Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted |
US8563566B2 (en) | 2007-08-01 | 2013-10-22 | Valeant Pharmaceuticals International | Naphthyridine derivatives as potassium channel modulators |
US7786146B2 (en) | 2007-08-13 | 2010-08-31 | Valeant Pharmaceuticals International | Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
AU2013240219A1 (en) | 2012-03-28 | 2014-10-09 | Neuropore Therapies, Inc. | Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation |
WO2020087234A1 (en) | 2018-10-29 | 2020-05-07 | 苏州大学张家港工业技术研究院 | Method for preparing benzyl amine compound |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3903989A1 (en) * | 1989-02-10 | 1990-09-20 | Basf Ag | DIPHENYLHETEROALKYL DERIVATIVES, THEIR PREPARATION, AND MEDICAMENTS AND COSMETICS THEREOF |
AU7317391A (en) * | 1990-02-14 | 1991-09-03 | Chugai Seiyaku Kabushiki Kaisha | Inhibitor of denatured ldl formation |
JPH05164223A (en) * | 1991-12-13 | 1993-06-29 | Nissan Motor Co Ltd | Vibration suppressing device of hydraulic control valve |
ATE272633T1 (en) * | 1998-12-23 | 2004-08-15 | Lilly Co Eli | AROMATIC AMIDES |
US6472165B1 (en) * | 1999-08-03 | 2002-10-29 | Arzneimittelwerk Dresden Gmbh | Modulatory binding site in potassium channels for screening and finding new active ingredients |
US6653332B2 (en) * | 2000-05-03 | 2003-11-25 | Tularik Inc. | Combination therapeutic compositions and method of use |
DE50107608D1 (en) * | 2000-08-31 | 2006-02-16 | Wella Ag | N-BENZYL-P-PHENYLENDIAMINE DERIVATIVES FOR KERATIN FIBERS AND NEW N-BENZYL-P-PHENYLENDIAMINE DERIVATIVES |
EP1369420A1 (en) * | 2002-06-06 | 2003-12-10 | Aventis Pharma Deutschland GmbH | Inhibitors of the GPib - vWF interaction |
-
2004
- 2004-03-12 JP JP2006504323A patent/JP2006520333A/en active Pending
- 2004-03-12 CA CA002519061A patent/CA2519061A1/en not_active Abandoned
- 2004-03-12 AU AU2004220424A patent/AU2004220424B2/en not_active Ceased
- 2004-03-12 WO PCT/DK2004/000162 patent/WO2004080950A1/en active Application Filing
- 2004-03-12 BR BRPI0408205-2A patent/BRPI0408205A/en not_active IP Right Cessation
- 2004-03-12 MX MXPA05009282A patent/MXPA05009282A/en not_active Application Discontinuation
- 2004-03-12 EP EP04719930A patent/EP1606247A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2006520333A (en) | 2006-09-07 |
EP1606247A1 (en) | 2005-12-21 |
WO2004080950A1 (en) | 2004-09-23 |
AU2004220424A1 (en) | 2004-09-23 |
CA2519061A1 (en) | 2004-09-23 |
MXPA05009282A (en) | 2005-10-05 |
AU2004220424B2 (en) | 2009-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0508570A (en) | compound, pharmaceutical composition, and use thereof | |
BRPI0408437A (en) | substituted p-diaminobenzene derivatives, pharmaceutical composition, and use thereof | |
BRPI0408205A (en) | substituted aniline derivative, pharmaceutical composition, and, use of a pharmaceutical composition | |
BRPI0408347A (en) | pyrimidine derivatives | |
CY1117470T1 (en) | SOLID DOSAGE PREPARATIONS WITH IMPROVED ANIMAL ADJUSTMENT | |
DK2314582T3 (en) | Heterocyclic compounds as antiviral agents | |
BRPI0715579A2 (en) | "compound, pharmaceutical composition and use of a compound" | |
NO20072978L (en) | New betuene derivatives, their preparation and their use | |
BRPI0407387A (en) | Nitrogen-substituted hexahydropyrazine [1,2-a] pyrimidin-4,7-dione derivatives, processes for their preparation and their application with medicament | |
BRPI0515174A (en) | compound or salts thereof, pharmaceutical composition, and use of a pharmaceutical | |
CY1111061T1 (en) | NEW HYDROCYCLIC UNIONS ACTIVE AS BETA-LACTAMA INHIBITIONS | |
BRPI0510453A (en) | Substituted Morpholine Compounds for the Treatment of Central Nervous System Disorders | |
BRPI0418102A (en) | quinoline derivatives | |
BR0214243A (en) | Sulfonamide derivative Process for the preparation of a sulfonamide derivative and its physiologically acceptable salts, pharmaceutical composition and use of a sulfonamide derivative | |
HRP20050213A2 (en) | 2,4-substituted indoles and their use as 5-ht6 modulators | |
DE602005010744D1 (en) | PIPERAZINYLPYRIDINE DERIVATIVES AS AGENTS AGAINST ADIPOSITAS | |
BRPI0512073A (en) | compound, pharmaceutical composition, and use thereof | |
TW200637817A (en) | 5-aminoindole derivatives | |
BRPI0417858A (en) | compound, pharmaceutical composition, and use of a pharmaceutical composition | |
BR0308338A (en) | Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress disorders | |
BRPI0409465A (en) | carboxamide derivatives as antidiabetic agents | |
BR0314352A (en) | 2,7-substituted indols and their use as 5-ht6 modulators | |
UY27018A1 (en) | PIRIMIDINE DERIVATIVES | |
BR0211995A (en) | Combination preparations of aryl substituted propanolamine derivatives with other active substances and their application | |
BRPI0417609B8 (en) | 3-cyano-quinoline derivatives with antiproliferative activity, their process of preparation and use and pharmaceutical composition comprising them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE AS 7A E 8A ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |